Purpose: This literature review was conducted to provide a summary of the findings from research on knowledge and attitudes about human papilloma virus (HPV) and HPV vaccination, and studies of its actual uptake among women in Asian countries. Methods: The author searched the Pubmed, CINAHL, and KISS electronic databases to identify peer-reviewed articles published between 2006 and 2011. Results: Seventeen peer-reviewed studies met the inclusion criteria (13 quantitative, 4 qualitative). Findings from seven Asian countries that measured female adult' s knowledge of HPV related issues and attitudes toward HPV vaccination were reviewed. Low level of knowledge about HPV and its related conditions, willingness to be vaccinated, and low uptake of vaccines were identified across the studies. Cultural barriers and social stigmatization about HPV vaccination were also discussed. Conclusion: Findings from this review indicate that adult women in Asian countries are in urgent need of improving HPV related knowledge and its actual vaccination. Policy makers, health care providers, and public health educators should take into account the cultural barriers and attitudes toward HPV vaccination in the process of developing and implementing educational programs and interventions for adult women in Asian countries.
INTRODUCTION
Cervical cancer is one of the most common cancers in women worldwide, and known as a preventable cancer threatening female health. 1, 2) Cervical cancer is not only the leading cause of death among middleaged women worldwide, but also contributes about fifty percent of the world's total cervical cancer cases in Asia Pacific region. 3) Human papillomavirus (HPV), one of the most common sexually transmitted infections, is related to almost all cervical cancers. 4) HPV infection is temporary and asymptomatic, and it is resolved naturally with no treatment. However, some high-risk cases of HPV infection could develop chronically and become a cause of cervical cancer. Out of more than 100 types of HPVs, HPV-16 and HPV-18 are the most common high-risk genotypes, and are accountable for 70% of cervical cancers. [3] [4] [5] Therefore, controlling HPV infection is crucial to prevent sexually transmitted diseases (STDs) and cervical cancer for women's health.
There have been two prophylactic HPV vaccines available in many countries since 2006, including Gardasil ® , as a quadrivalent vaccine, and Cervarix TM , as a bivalent vaccine. 4, 6) Research has indicated that about 30-60% of sexually active adults are infected by HPV at some point in their lives, 5) and young adults are especially at risk of high prevalence of HPV infection. 2) Despite the effects and importance of HPV vaccination in preventing cervical cancer, women's knowledge of HPV vaccine and its uptake have been reported low worldwide. 2, 9) In addition, statistics in Western countries reported that about 37-50% of adolescent had limited knowledge level about HPV and HPV vaccine. 2, 10, 11) Little is known about young women's knowledge of HPV in the South-East Asia region. Across studies conducted in the west, HPV vaccination acceptability was relatively positive. However, this could be different in Asian countries since cultural belief, family and social norm toward STDs and its prevention are different. [14] [15] [16] The purpose of this review is to provide a summary of findings from studies of attitudes and knowledge about HPV and HPV vaccination, and actual uptake studies that have been performed in Asian countries.
METHODS
The author mainly searched the Pubmed, Cumulative Index to Nurs- 
RESULTS
The selected articles ( 
Knowledge of HPV and HPV vaccination
Most studies that were reviewed explored adult women's knowledge level about HPV and HPV vaccination ( Table 2 ). Most of the subjects showed poor knowledge on HPV and its vaccine. A range of 53-90% of women in these studies had never heard of HPV. 1, 2, 14, 16, 23, 24) Since most of the research participants showed a lack of knowledge in HPV, they also displayed poor knowledge about HPV vaccination and its preventable effects on cervical cancer. 8, 14, 16, 18, [23] [24] [25] Across six studies, only 6-48% of women knew that HPV can cause cervical cancer 8, 14, 20, 23, 25, 26) and approximately 19-31.5% of participants were aware of the sexually transmitted nature of HPV infection and its connection to cervical cancer. 8, 16, 25) Levels and measure of HPV and HPV vaccine varied greatly across the studies. Ten of thirteen quantitative studies measured the knowledge level of HPV and its related issues, and seven articles assessed knowledge as a dichotomized or categorized outcome. Only three studies measured level of knowledge of HPV using test questionnaire and evaluated mean scores, 1, 18, 19) while the other studies simply asked their participants whether they have heard of HP V and HPV vaccine. According to Lee and Park (2011) , the mean knowledge score was 13.75 ± 2.41 (range 0-23) among female college students in Korea, representing 60 percent of correct answer rate. 18) Other two studies reported approximately 23.8-45.9%
of correct answer rate about HPV knowledge. 19, 21) Qualitative studies showed similar findings from quantitative studies.
Most participants in these studies severely lacked knowledge in HPV and HPV vaccine. 1, 20, 27, 28) About ninety percent of them said that they had never heard of HPV and HPV vaccine, while 83% heard about cervical cancer. willingness to be vaccinated. The majority of women reported positive attitudes toward HPV vaccination, and a range of 48-88% responded that they would like to be vaccinated. 2, 14, 16, [23] [24] [25] The reasons for the positive response were the fear of having genital warts (31.9%) and concern about being infected by HPV (56.6%). 8, 16, 23) Two studies reported that younger age was identified as a factor for the positive intent to be vaccinated. 8, 16) In the study by Charakorn et al. Several causes for the participants' unwillingness to be vaccinated were also identified across the studies. Concerns about possible side effects and issues of safety and efficacy were discussed as potential barriers for vaccination. 2, 20, [23] [24] [25] 27, 28) High cost of HPV vaccine 8, 17, 24, 26, 28) and the participants' perception of HPV as not being a risk 2, 14, 16, 28) were also identified as reasons for the concern. Several studies discussed social stigma and embarrassment to receive STD vaccine, and these factors might be the reasons for the negative attitude toward HPV vaccination. 
Actual uptake of HPV vaccination
Most studies reviewed did not aim to investigate the actual uptake of HPV vaccine for adult women. Among the 17 studies examined, only 6 studies reported the uptake of HPV vaccine. 14, 17, 18, 21, 22, 24) The actual uptake rate of HPV vaccination was very low. In a study that compared the knowledge level between vaccinated group and un-vaccinated group, the uptake rate was 20.9%. 21 initiated HPV vaccination, and therefore reported an 100% uptake rate, the average uptake rate of HPV vaccine was 1.4%, ranging from 0.009% to 8%. 14, 17, 18, 24) 
DISCUSSION
The 
